 | • レポートコード：QYR2104Z2951 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ヒトマイクロバイオーム治療薬・診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治療、診断）、用途別市場規模（臨床研究所、病院、手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ヒトマイクロバイオーム治療薬・診断の市場動向 ・企業の競争状況、市場シェア ・ヒトマイクロバイオーム治療薬・診断の種類別市場規模（治療、診断） ・ヒトマイクロバイオーム治療薬・診断の用途別市場規模（臨床研究所、病院、手術センター、その他） ・ヒトマイクロバイオーム治療薬・診断の北米市場規模2016-2027（アメリカ、カナダ） ・ヒトマイクロバイオーム治療薬・診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ヒトマイクロバイオーム治療薬・診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ヒトマイクロバイオーム治療薬・診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・ヒトマイクロバイオーム治療薬・診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Second Genome、Enterome Bioscience、Yakult、Dowdupont、Vedanta BioSciences、Metabiomics Corporation、ViThera Pharmaceuticals、MicroBiome Therapeutics、Osel、Merck） ・結論 |
The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness.
Rising cases of chronic diseases such as diabetes, disorders at early stage and the ability of the drugs to diagnose them and increased awareness among people to maintain healthy lifestyle is driving the growth of this market.
Market Analysis and Insights: Global Human Microbiome Based Drugs and Diagnostics Market
The global Human Microbiome Based Drugs and Diagnostics market size is projected to reach US$ 1659 million by 2026, from US$ 827.9 million in 2019, at a CAGR of 10.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Microbiome Based Drugs and Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Microbiome Based Drugs and Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Microbiome Based Drugs and Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Microbiome Based Drugs and Diagnostics market.
Global Human Microbiome Based Drugs and Diagnostics Scope and Market Size
Human Microbiome Based Drugs and Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Microbiome Based Drugs and Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Therapeutics
Diagnostics
Segment by Application
Clinical Research Institutes
Hospital
Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Second Genome
Enterome Bioscience
Yakult
Dowdupont
Vedanta BioSciences
Metabiomics Corporation
ViThera Pharmaceuticals
MicroBiome Therapeutics
Osel
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Microbiome Based Drugs and Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Therapeutics
1.2.3 Diagnostics
1.3 Market by Application
1.3.1 Global Human Microbiome Based Drugs and Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Research Institutes
1.3.3 Hospital
1.3.4 Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Based Drugs and Diagnostics Market Perspective (2016-2027)
2.2 Human Microbiome Based Drugs and Diagnostics Growth Trends by Regions
2.2.1 Human Microbiome Based Drugs and Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Human Microbiome Based Drugs and Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Human Microbiome Based Drugs and Diagnostics Industry Dynamic
2.3.1 Human Microbiome Based Drugs and Diagnostics Market Trends
2.3.2 Human Microbiome Based Drugs and Diagnostics Market Drivers
2.3.3 Human Microbiome Based Drugs and Diagnostics Market Challenges
2.3.4 Human Microbiome Based Drugs and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Microbiome Based Drugs and Diagnostics Players by Revenue
3.1.1 Global Top Human Microbiome Based Drugs and Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Human Microbiome Based Drugs and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Human Microbiome Based Drugs and Diagnostics Revenue
3.4 Global Human Microbiome Based Drugs and Diagnostics Market Concentration Ratio
3.4.1 Global Human Microbiome Based Drugs and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Based Drugs and Diagnostics Revenue in 2020
3.5 Human Microbiome Based Drugs and Diagnostics Key Players Head office and Area Served
3.6 Key Players Human Microbiome Based Drugs and Diagnostics Product Solution and Service
3.7 Date of Enter into Human Microbiome Based Drugs and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Based Drugs and Diagnostics Breakdown Data by Type
4.1 Global Human Microbiome Based Drugs and Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Type (2022-2027)
5 Human Microbiome Based Drugs and Diagnostics Breakdown Data by Application
5.1 Global Human Microbiome Based Drugs and Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Human Microbiome Based Drugs and Diagnostics Market Size (2016-2027)
6.2 North America Human Microbiome Based Drugs and Diagnostics Market Size by Type
6.2.1 North America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2027)
6.3 North America Human Microbiome Based Drugs and Diagnostics Market Size by Application
6.3.1 North America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2027)
6.4 North America Human Microbiome Based Drugs and Diagnostics Market Size by Country
6.4.1 North America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Human Microbiome Based Drugs and Diagnostics Market Size (2016-2027)
7.2 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Type
7.2.1 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2027)
7.3 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Application
7.3.1 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2027)
7.4 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Country
7.4.1 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Type
8.2.1 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Application
8.3.1 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Region
8.4.1 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Human Microbiome Based Drugs and Diagnostics Market Size (2016-2027)
9.2 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Type
9.2.1 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Application
9.3.1 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Country
9.4.1 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Type
10.2.1 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Application
10.3.1 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Country
10.4.1 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Second Genome
11.1.1 Second Genome Company Details
11.1.2 Second Genome Business Overview
11.1.3 Second Genome Human Microbiome Based Drugs and Diagnostics Introduction
11.1.4 Second Genome Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
11.1.5 Second Genome Recent Development
11.2 Enterome Bioscience
11.2.1 Enterome Bioscience Company Details
11.2.2 Enterome Bioscience Business Overview
11.2.3 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Introduction
11.2.4 Enterome Bioscience Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
11.2.5 Enterome Bioscience Recent Development
11.3 Yakult
11.3.1 Yakult Company Details
11.3.2 Yakult Business Overview
11.3.3 Yakult Human Microbiome Based Drugs and Diagnostics Introduction
11.3.4 Yakult Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
11.3.5 Yakult Recent Development
11.4 Dowdupont
11.4.1 Dowdupont Company Details
11.4.2 Dowdupont Business Overview
11.4.3 Dowdupont Human Microbiome Based Drugs and Diagnostics Introduction
11.4.4 Dowdupont Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
11.4.5 Dowdupont Recent Development
11.5 Vedanta BioSciences
11.5.1 Vedanta BioSciences Company Details
11.5.2 Vedanta BioSciences Business Overview
11.5.3 Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Introduction
11.5.4 Vedanta BioSciences Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
11.5.5 Vedanta BioSciences Recent Development
11.6 Metabiomics Corporation
11.6.1 Metabiomics Corporation Company Details
11.6.2 Metabiomics Corporation Business Overview
11.6.3 Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Introduction
11.6.4 Metabiomics Corporation Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
11.6.5 Metabiomics Corporation Recent Development
11.7 ViThera Pharmaceuticals
11.7.1 ViThera Pharmaceuticals Company Details
11.7.2 ViThera Pharmaceuticals Business Overview
11.7.3 ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Introduction
11.7.4 ViThera Pharmaceuticals Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
11.7.5 ViThera Pharmaceuticals Recent Development
11.8 MicroBiome Therapeutics
11.8.1 MicroBiome Therapeutics Company Details
11.8.2 MicroBiome Therapeutics Business Overview
11.8.3 MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Introduction
11.8.4 MicroBiome Therapeutics Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
11.8.5 MicroBiome Therapeutics Recent Development
11.9 Osel
11.9.1 Osel Company Details
11.9.2 Osel Business Overview
11.9.3 Osel Human Microbiome Based Drugs and Diagnostics Introduction
11.9.4 Osel Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
11.9.5 Osel Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Human Microbiome Based Drugs and Diagnostics Introduction
11.10.4 Merck Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
11.10.5 Merck Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Human Microbiome Based Drugs and Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Therapeutics
Table 3. Key Players of Diagnostics
Table 4. Global Human Microbiome Based Drugs and Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Human Microbiome Based Drugs and Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Human Microbiome Based Drugs and Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Human Microbiome Based Drugs and Diagnostics Market Share by Regions (2016-2021)
Table 8. Global Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Human Microbiome Based Drugs and Diagnostics Market Share by Regions (2022-2027)
Table 10. Human Microbiome Based Drugs and Diagnostics Market Trends
Table 11. Human Microbiome Based Drugs and Diagnostics Market Drivers
Table 12. Human Microbiome Based Drugs and Diagnostics Market Challenges
Table 13. Human Microbiome Based Drugs and Diagnostics Market Restraints
Table 14. Global Human Microbiome Based Drugs and Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Human Microbiome Based Drugs and Diagnostics Market Share by Players (2016-2021)
Table 16. Global Top Human Microbiome Based Drugs and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Based Drugs and Diagnostics as of 2020)
Table 17. Ranking of Global Top Human Microbiome Based Drugs and Diagnostics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Human Microbiome Based Drugs and Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Microbiome Based Drugs and Diagnostics Product Solution and Service
Table 21. Date of Enter into Human Microbiome Based Drugs and Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Type (2016-2021)
Table 25. Global Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Human Microbiome Based Drugs and Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Application (2016-2021)
Table 29. Global Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Human Microbiome Based Drugs and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Human Microbiome Based Drugs and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Second Genome Company Details
Table 62. Second Genome Business Overview
Table 63. Second Genome Human Microbiome Based Drugs and Diagnostics Product
Table 64. Second Genome Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
Table 65. Second Genome Recent Development
Table 66. Enterome Bioscience Company Details
Table 67. Enterome Bioscience Business Overview
Table 68. Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Product
Table 69. Enterome Bioscience Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
Table 70. Enterome Bioscience Recent Development
Table 71. Yakult Company Details
Table 72. Yakult Business Overview
Table 73. Yakult Human Microbiome Based Drugs and Diagnostics Product
Table 74. Yakult Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
Table 75. Yakult Recent Development
Table 76. Dowdupont Company Details
Table 77. Dowdupont Business Overview
Table 78. Dowdupont Human Microbiome Based Drugs and Diagnostics Product
Table 79. Dowdupont Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
Table 80. Dowdupont Recent Development
Table 81. Vedanta BioSciences Company Details
Table 82. Vedanta BioSciences Business Overview
Table 83. Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Product
Table 84. Vedanta BioSciences Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
Table 85. Vedanta BioSciences Recent Development
Table 86. Metabiomics Corporation Company Details
Table 87. Metabiomics Corporation Business Overview
Table 88. Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Product
Table 89. Metabiomics Corporation Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
Table 90. Metabiomics Corporation Recent Development
Table 91. ViThera Pharmaceuticals Company Details
Table 92. ViThera Pharmaceuticals Business Overview
Table 93. ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Product
Table 94. ViThera Pharmaceuticals Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
Table 95. ViThera Pharmaceuticals Recent Development
Table 96. MicroBiome Therapeutics Company Details
Table 97. MicroBiome Therapeutics Business Overview
Table 98. MicroBiome Therapeutics Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
Table 99. MicroBiome Therapeutics Recent Development
Table 100. Osel Company Details
Table 101. Osel Business Overview
Table 102. Osel Human Microbiome Based Drugs and Diagnostics Product
Table 103. Osel Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
Table 104. Osel Recent Development
Table 105. Merck Company Details
Table 106. Merck Business Overview
Table 107. Merck Human Microbiome Based Drugs and Diagnostics Product
Table 108. Merck Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
Table 109. Merck Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Microbiome Based Drugs and Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Therapeutics Features
Figure 3. Diagnostics Features
Figure 4. Global Human Microbiome Based Drugs and Diagnostics Market Share by Application: 2020 VS 2027
Figure 5. Clinical Research Institutes Case Studies
Figure 6. Hospital Case Studies
Figure 7. Surgical Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Human Microbiome Based Drugs and Diagnostics Report Years Considered
Figure 10. Global Human Microbiome Based Drugs and Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Human Microbiome Based Drugs and Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Human Microbiome Based Drugs and Diagnostics Market Share by Regions: 2020 VS 2027
Figure 13. Global Human Microbiome Based Drugs and Diagnostics Market Share by Regions (2022-2027)
Figure 14. Global Human Microbiome Based Drugs and Diagnostics Market Share by Players in 2020
Figure 15. Global Top Human Microbiome Based Drugs and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Based Drugs and Diagnostics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Human Microbiome Based Drugs and Diagnostics Revenue in 2020
Figure 17. Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Type (2016-2021)
Figure 18. Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Type (2022-2027)
Figure 19. North America Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Human Microbiome Based Drugs and Diagnostics Market Share by Type (2016-2027)
Figure 21. North America Human Microbiome Based Drugs and Diagnostics Market Share by Application (2016-2027)
Figure 22. North America Human Microbiome Based Drugs and Diagnostics Market Share by Country (2016-2027)
Figure 23. United States Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Human Microbiome Based Drugs and Diagnostics Market Share by Type (2016-2027)
Figure 27. Europe Human Microbiome Based Drugs and Diagnostics Market Share by Application (2016-2027)
Figure 28. Europe Human Microbiome Based Drugs and Diagnostics Market Share by Country (2016-2027)
Figure 29. Germany Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Share by Region (2016-2027)
Figure 39. China Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Human Microbiome Based Drugs and Diagnostics Market Share by Type (2016-2027)
Figure 47. Latin America Human Microbiome Based Drugs and Diagnostics Market Share by Application (2016-2027)
Figure 48. Latin America Human Microbiome Based Drugs and Diagnostics Market Share by Country (2016-2027)
Figure 49. Mexico Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Share by Country (2016-2027)
Figure 55. Turkey Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Second Genome Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
Figure 59. Enterome Bioscience Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
Figure 60. Yakult Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
Figure 61. Dowdupont Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
Figure 62. Vedanta BioSciences Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
Figure 63. Metabiomics Corporation Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
Figure 64. ViThera Pharmaceuticals Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
Figure 65. MicroBiome Therapeutics Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
Figure 66. Osel Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
Figure 67. Merck Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界のヒトマイクロバイオーム治療市場規模・現状・予測（2021年-2027年） Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of the fastest growing areas of biology, and is considered as a newly discovered organ with the potential to have a tremendous impact on human health. Mic…- 世界のマイクロバイオーム医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Microbiome Drugs Market The global Microbiome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a b…
- 世界のヒトマイクロバイオーム市場規模・現状・予測（2021年-2027年） The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a to…
- 世界のヒトマイクロバイオームシーケンシング市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Microbiome Sequencing Market The global Human Microbiome Sequencing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
- 世界のヒトマイクロバイオームシーケンシング技術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Microbiome Sequencing Technology Market The global Human Microbiome Sequencing Technology market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…